Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
NIZAC nizatidine 300 mg capsule blister pack, Arrow Pharma Pty Ltd, CON-1128
Product name
NIZAC nizatidine 300 mg capsule blister pack
Sponsor name
Arrow Pharma Pty Ltd
Batches
7752569A,7752619A and 7752620A
Consent start
Consent no.
CON-1128
Standard
Subparagraph 8(3)(e) of Therapeutic Goods Order No. 91 - Standard for labels of prescription and related medicines
Non-compliance with standard
The product(s) do not include the correct expiry date, that is, the date that
'in relation to a product means the date (month and year) after which the
medicine should not be used
Conditions imposed
1. A 'Dear Healthcare Provider' letter identical to that provided to the
Therapeutic Goods Administration on 6 July 2023 will be supplied with each
affected batch including the updated shelf life for each batch.
Therapeutic product type
Prescription medicines